Generic Medicine Info
Hypersensitivity to gonadotrophin-releasing hormone (GnRH) or any other GnRH analogue. Moderate to severe renal or hepatic impairment. Pregnancy and lactation.
Special Precautions
Women w/ signs and symptoms of active allergic conditions. Monitoring Parameters Perform ultrasound to assess follicle size.
Adverse Reactions
Hypersensitivity reactions including anaphylactoid reactions, headache, nausea, GI abdominal pain, neutrophil count ≥8.3/mm3, gynaecologic abdominal pain, ovarian hyperstimulation syndrome, vag bleeding, inj site reactions, foetal death.
Drug Interactions
May require dose adjustment of exogenous gonadotropins when concomitantly used during controlled ovarian hyperstimulation.
ATC Classification
H01CC01 - ganirelix ; Belongs to the class of anti-gonadotropin-releasing hormones. Used in hypothalamic hormone preparations.
Disclaimer: This information is independently developed by CIMS based on ganirelix from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in